Free tool
FAERS Monitor: Suboxone
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022410 or its brand name (Suboxone, Buprenorphine Hydrochloride, Naloxone Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
24,312
Serious
15,334
63% of reports
Hospitalization
4,906
Death reported
1,271
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug dependence4,326
- drug withdrawal syndrome3,371
- pain2,574
- off label use2,109
- overdose1,871
- nausea1,664
- emotional distress1,485
- anxiety1,371
- vomiting1,350
- drug abuse1,132
- headache1,129
- insomnia1,089
- foetal exposure during pregnancy1,064
- depression1,043
- intentional underdose1,028
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 19 |
| 2005 | 33 |
| 2006 | 103 |
| 2007 | 163 |
| 2008 | 239 |
| 2009 | 442 |
| 2010 | 1,163 |
| 2011 | 1,071 |
| 2012 | 835 |
| 2013 | 504 |
| 2014 | 2,267 |
| 2015 | 2,187 |
| 2016 | 1,723 |
| 2017 | 1,850 |
| 2018 | 1,690 |
| 2019 | 1,265 |
| 2020 | 1,804 |
| 2021 | 2,628 |
| 2022 | 1,483 |
| 2023 | 838 |
| 2024 | 637 |
| 2025 | 788 |
| 2026 | 580 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,847 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| intentional underdoseSignal | 1,028 | 141.5 | 132.6 | 123,177 |
| drug withdrawal syndromeSignal | 3,371 | 34.5 | 33.4 | 105,929 |
| drug dependenceSignal | 4,326 | 23.9 | 23.2 | 93,020 |
| drug abuseSignal | 1,132 | 11.9 | 11.2 | 11,196 |
| foetal exposure during pregnancySignal | 1,064 | 11.5 | 10.8 | 10,055 |
| emotional distressSignal | 1,485 | 10.7 | 10.2 | 13,008 |
| overdoseSignal | 1,871 | 7.6 | 7.2 | 10,662 |
| anxietySignal | 1,371 | 4.2 | 4.0 | 3,347 |
| depressionSignal | 1,043 | 4.0 | 3.7 | 2,338 |
| painSignal | 2,574 | 3.6 | 3.5 | 5,043 |
| insomniaSignal | 1,089 | 3.5 | 3.3 | 2,007 |
| vomitingSignal | 1,350 | 2.5 | 2.4 | 1,224 |
| off label useSignal | 2,109 | 2.1 | 2.0 | 1,241 |
| nausea | 1,664 | 1.8 | 1.7 | 637 |
| headache | 1,129 | 1.6 | 1.5 | 232 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.